Comparison of pharmacokinetic characteristics of two Tegoprazan (CJ-12420) formulations in healthy male subjects

Proton-pump inhibitors (PPIs) are effectively used to treat acid-related diseases, including gastroesophageal reflux disease (GERD); however, many unmet medical needs still exist. As a new treatment option, potassium-competitive acid blockers (P-CABs), such as tegoprazan, have been developed. This s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Clin Pharmacol
Main Authors: Hwang, Jun Gi, Yoo, Hyounggyoon, Lee, Ji Won, Song, Geun Seog, Lee, SeungHwan, Kim, Min-Gul
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society for Clinical Pharmacology and Therapeutics 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989242/
https://ncbi.nlm.nih.gov/pubmed/32055586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2019.27.2.80
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados